Sign in

CIK 0001840229 · <br>Emerging growth company

MiNK Therapeutics, Inc.

Sign in to watch
Ticker
INKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
212-994-8250
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
  1. 8-K Event Results of operations
  2. 8-K Event Results of operations
  3. 8-K Event Shareholder vote results
  4. 8-K Event Results of operations
  5. 8-K Event Results of operations
  6. 8-K Event Other events
  7. 8-K Event Executive or director change
  8. 8-K Event Executive or director change
  9. 8-K Event Results of operations
  10. 8-K Event Executive or director change
  11. 8-K Event Results of operations
  12. 8-K Event Material agreement
  13. 8-K Event Other events
  14. 8-K Event Shareholder vote results
  15. 8-K Event Results of operations
  16. 8-K Event Results of operations
  17. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  18. 8-K Event Results of operations
  19. 8-K Event Executive or director change
  20. 8-K Event Executive or director change

Page 1 of 3 · 43 filings